Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

OGN

Organon & Co

Sep 12 • 04:00PM ET

10.65

-0.01 -0.09 %

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: PFE MRK JNJ NVS ABBV LLY BMY GSK AZN BIIB

| Held by: IJR VTI VB VBR VXF IJS SPSM FXH SLYV DES

Scroll to Statements

Index	-	P/E	3.96	EPS (ttm)	2.69	Insider Own	0.37%	Shs Outstand	259.96M	Perf Week	2.60%
Market Cap	2.77B	Forward P/E	2.63	EPS next Y	4.04	Insider Trans	8.45%	Shs Float	259.01M	Perf Month	13.78%
Enterprise Value	11.07B	PEG	5.21	EPS next Q	0.93	Inst Own	84.23%	Short Float	5.76%	Perf Quarter	5.76%
Income	700.00M	P/S	0.44	EPS this Y	-6.87%	Inst Trans	4.86%	Short Ratio	3.73	Perf Half Y	-28.81%
Sales	6.28B	P/B	3.78	EPS next Y	5.62%	ROA	5.46%	Short Interest	14.91M	Perf YTD	-28.62%
Book/sh	2.82	P/C	4.62	EPS next 5Y	0.76%	ROE	159.64%	52W High	21.06 -49.42%	Perf Year	-46.99%
Cash/sh	2.30	P/FCF	4.21	EPS past 3/5Y	-14.47% -23.49%	ROIC	7.36%	52W Low	8.01 32.96%	Perf 3Y	-63.23%
Dividend Est.	0.25 (2.38%)	EV/EBITDA	6.65	Sales past 3/5Y	0.22% -7.65%	Gross Margin	56.26%	Volatility	3.39% 3.47%	Perf 5Y	-
Dividend TTM	0.60 (5.63%)	EV/Sales	1.76	EPS Y/Y TTM	-30.57%	Oper. Margin	21.41%	ATR (14)	0.37	Perf 10Y	-
Dividend Ex-Date	Aug 15, 2025	Quick Ratio	1.13	Sales Y/Y TTM	-1.02%	Profit Margin	11.14%	RSI (14)	67.18	Recom	3.00
Dividend Gr. 3/5Y	25.99% -	Current Ratio	1.65	EPS Q/Q	-26.08%	SMA20	9.96%	Beta	0.58	Target Price	13.17
Payout	33.59%	Debt/Eq	12.14	Sales Q/Q	-0.81%	SMA50	10.36%	Rel Volume	0.67	Prev Close	10.66
Employees	10000	LT Debt/Eq	11.98	Earnings	Aug 05 BMO	SMA200	-13.40%	Avg Volume	4.00M	Price	10.65
IPO	May 14, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	5.43% 2.72%	Trades		Volume	2,698,168	Change	-0.09%

Date	Action	Analyst	Rating Change	Price Target Change
May-02-25	Downgrade	Evercore ISI	Outperform → In-line
Sep-06-24	Downgrade	JP Morgan	Neutral → Underweight	$18 → $20
Nov-03-23	Downgrade	Goldman	Buy → Neutral	$33 → $16
Sep-21-23	Initiated	Barclays	Overweight	$28
Mar-16-23	Initiated	Raymond James	Outperform	$33
Oct-14-22	Downgrade	BofA Securities	Neutral → Underperform	$27 → $25
Sep-06-22	Upgrade	Piper Sandler	Neutral → Overweight	$37 → $34
Aug-05-22	Downgrade	BofA Securities	Buy → Neutral	$40 → $37
Apr-27-22	Initiated	Goldman	Buy	$40
Apr-06-22	Resumed	Morgan Stanley	Equal-Weight	$35
Oct-07-21	Initiated	Piper Sandler	Neutral	$35
Sep-01-21	Initiated	BofA Securities	Buy	$43
Jul-22-21	Initiated	Citigroup	Buy	$35
Jun-15-21	Initiated	JP Morgan	Neutral	$38
Jun-11-21	Initiated	Morgan Stanley	Equal-Weight	$33
Jun-10-21	Initiated	Evercore ISI	Outperform

Show Previous Ratings

Sep-12-25 09:00AM	Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Sep-11-25 11:55AM	Why Organon (OGN) Stock Is Trading Up Today (StockStory)
12:35AM	3 Stocks Under $50 We Find Risky (StockStory)
Sep-10-25 05:50PM	Organon (OGN) Stock Declines While Market Improves: Some Information for Investors (Zacks)
Sep-02-25 05:30AM	US Food and Drug Administration (FDA) Approves Henlius and Organons BILDYOS (denosumab-nxxp) and BILPREVDA (denosumab-nxxp), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively (Business Wire)
05:04AM	Loading…
Aug-29-25 05:04AM	Organon & Co. (OGN) Advances VTAMA Cream, Strengthens Women's Health Portfolio (Insider Monkey)
Aug-25-25 09:00AM	Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Aug-13-25 12:10AM	OGN Q2 Deep Dive: Flat Sales, Margin Pressure, and Strategic Shifts Highlight Quarter (StockStory)
12:02AM	5 Must-Read Analyst Questions From Organon's Q2 Earnings Call (StockStory)
Aug-12-25 09:00AM	Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know (Zacks)
08:00AM	Eureka Therapeutics Appoints Dr. Reginald Seeto and William S. Solari III to Board of Directors (Business Wire)
Aug-08-25 11:40AM	OGN vs. HQY: Which Stock Is the Better Value Option? (Zacks)
Aug-07-25 01:01PM	Organon & Co. (OGN) Reports Q2 2025 Results (Insider Monkey)
Aug-06-25 12:22PM	Organon & Co. (OGN) Slashes 13.13% on Disappointing Earnings (Insider Monkey)
Aug-05-25 11:00AM	Organon (OGN) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks) -13.13%
08:45AM	Loading…
08:45AM	Organon (OGN) Beats Q2 Earnings and Revenue Estimates (Zacks)
08:04AM	Organon (NYSE:OGN) Surprises With Q2 Sales, Stock Soars (StockStory)
07:42AM	Organon: Q2 Earnings Snapshot (Associated Press Finance)
07:30AM	Organon Reports Results for the Second Quarter Ended June 30, 2025 (Business Wire)
Aug-04-25 08:50AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
Aug-03-25 11:07PM	Organon Earnings: What To Look For From OGN (StockStory)
Aug-01-25 09:15AM	Insights Into Organon (OGN) Q2: Wall Street Projections for Key Metrics (Zacks)
Jul-31-25 05:50PM	Organon (OGN) Sees a More Significant Dip Than Broader Market: Some Facts to Know (Zacks)
Jul-30-25 10:00AM	Cencora (COR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Jul-29-25 10:00AM	Organon (OGN) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Jul-25-25 05:50PM	Organon (OGN) Outperforms Broader Market: What You Need to Know (Zacks)
Jul-23-25 09:00AM	Here is What to Know Beyond Why Organon & Co. (OGN) is a Trending Stock (Zacks)
Jul-22-25 08:50AM	How to Find Strong Medical Stocks Slated for Positive Earnings Surprises (Zacks)
07:30AM	Organon To Report Second Quarter 2025 Results and Host Conference Call on August 5, 2025 (Business Wire)
Jul-21-25 06:33PM	Organon & Co. (OGN) Restructures, Expands in Women's Health and Biosimilars (Insider Monkey)
11:40AM	Loading…
11:40AM	OGN or MEDP: Which Is the Better Value Stock Right Now? (Zacks)
09:19AM	Organon & Co. (OGN) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before July 22, 2025 (Newsfile)
09:15AM	OGN Shareholders Have the Right to Lead the Organon & Co. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - OGN (PR Newswire)
Jul-18-25 05:50PM	Organon (OGN) Registers a Bigger Fall Than the Market: Important Facts to Note (Zacks)
Jul-17-25 11:34PM	Unpacking Q1 Earnings: Organon (NYSE:OGN) In The Context Of Other Branded Pharmaceuticals Stocks (StockStory)
Jul-15-25 12:10PM	Why Organon (OGN) is Poised to Beat Earnings Estimates Again (Zacks)
Jul-11-25 11:28AM	Organon & Co. (OGN) Announces American Academy of Dermatology's Strong Recommendation for VTAMA Cream (Insider Monkey)
Jul-10-25 06:00PM	Organon (OGN) Outperforms Broader Market: What You Need to Know (Zacks)
11:13AM	Organon & Co. (OGN) Announces Discontinuation of the OG-6219 Clinical Development Program (Insider Monkey)
Jul-09-25 09:00AM	Is Trending Stock Organon & Co. (OGN) a Buy Now? (Zacks)
Jul-08-25 01:50PM	Trade Tracker: Jenny Harrington sells Organon and buys Vici Properties (CNBC TV)
Jul-07-25 07:30AM	Organons VTAMA (tapinarof) cream, 1%, Granted Strong Recommendation in the American Academy of Dermatology Updated 2025 Guidelines for Adult Atopic Dermatitis (Business Wire)
Jul-03-25 05:50PM	Organon (OGN) Stock Dips While Market Gains: Key Facts (Zacks)
11:40AM	OGN vs. MEDP: Which Stock Is the Better Value Option? (Zacks)
Jul-02-25 07:30AM	Organon Provides Update on Phase 2 ELENA Proof-of-Concept Study Evaluating OG-6219 in Patients with Endometriosis-Related Pain (Business Wire)
Jul-01-25 09:00AM	Organon & Co. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - OGN (PR Newswire)
Jun-27-25 05:50PM	Organon (OGN) Stock Sinks As Market Gains: What You Should Know (Zacks)
Jun-26-25 03:10AM	5 Must-Read Analyst Questions From Organon's Q1 Earnings Call (StockStory)
Jun-25-25 09:00AM	Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Jun-24-25 06:00PM	Organon (OGN) Outpaces Stock Market Gains: What You Should Know (Zacks)
Jun-17-25 12:00PM	All You Need to Know About Organon (OGN) Rating Upgrade to Buy (Zacks)
11:40AM	OGN or DOCS: Which Is the Better Value Stock Right Now? (Zacks)
Jun-16-25 05:50PM	Organon (OGN) Exceeds Market Returns: Some Facts to Consider (Zacks)
Jun-13-25 10:13AM	OGN Shareholders Have the Right to Lead the Organon & Co. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - OGN (PR Newswire)
09:00AM	Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Jun-02-25 03:59PM	Shareholders who lost money on Organon & Co. (NYSE: OGN) Should Contact Wolf Haldenstein (PR Newswire)
09:00AM	Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know (Zacks)
May-27-25 07:30AM	US Food and Drug Administration (FDA) Grants Interchangeability Designation to Samsung Bioepis and Organon HADLIMA (adalimumab-bwwd) Injection (Business Wire) +5.18%
May-20-25 12:42PM	Why Organon & Co.'s (OGN) Surged Last Week (Insider Monkey)
May-06-25 09:00AM	Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know (Zacks)
May-05-25 12:35AM	3 Value Stocks with Questionable Fundamentals (StockStory) -9.07%
May-02-25 02:06PM	Organon price target lowered to $10 from $11 at BofA (TipRanks)
10:00AM	Why The Low Payout Ratio Did Not Stop The Dividend Cut For Organon (Seeking Alpha)
May-01-25 11:31AM	Organon & Co. (OGN) Q1 2025 Earnings Call Transcript (Seeking Alpha) -26.91%
10:30AM	Organon (OGN) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks)
08:10AM	Organon (OGN) Q1 Earnings Surpass Estimates (Zacks)
07:00AM	Organon Reports Results for the First Quarter Ended March 31, 2025 (Business Wire)
Apr-28-25 09:15AM	Countdown to Organon (OGN) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS (Zacks)
Apr-27-25 01:13PM	3 Cash-Producing Stocks with Questionable Fundamentals (StockStory)
Apr-25-25 06:00PM	Organon (OGN) Ascends But Remains Behind Market: Some Facts to Note (Zacks)
10:00AM	BrightSpring Health Services, Inc. (BTSG) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
09:00AM	Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Apr-24-25 10:01AM	Analysts Estimate Organon (OGN) to Report a Decline in Earnings: What to Look Out for (Zacks) +5.48%
Apr-22-25 07:10AM	Elevance Health (ELV) Surpasses Q1 Earnings and Revenue Estimates (Zacks) +5.74%
Apr-21-25 05:25PM	Medpace (MEDP) Q1 Earnings and Revenues Beat Estimates (Zacks)
Apr-16-25 02:41PM	IYH: Healthcare Dashboard For April (Seeking Alpha)
Apr-15-25 05:00PM	Organon Appoints Ramona A. Sequeira to the Companys Board of Directors (Business Wire)
07:31AM	Organon To Report First Quarter 2025 Results and Host Conference Call on May 1, 2025 (Business Wire)
Apr-14-25 06:00PM	Organon (OGN) Laps the Stock Market: Here's Why (Zacks)
09:00AM	Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know (Zacks)
Apr-10-25 09:13AM	Strength Seen in Organon (OGN): Can Its 8.5% Jump Turn into More Strength? (Zacks) -9.57%
Apr-08-25 09:21PM	Lightning Round: ServiceNow is an expensive stock in a market that no longer loves expensive stocks (CNBC TV) -6.95% +8.50%
05:07AM	Q4 Earnings Roundup: Organon (NYSE:OGN) And The Rest Of The Branded Pharmaceuticals Segment (StockStory)
Apr-07-25 05:06AM	Organon (OGN): Buy, Sell, or Hold Post Q4 Earnings? (StockStory)
Apr-03-25 05:50PM	Organon (OGN) Stock Moves -1.83%: What You Should Know (Zacks) -9.69%
08:50AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
Apr-02-25 12:10PM	Why Organon (OGN) Could Beat Earnings Estimates Again (Zacks)
08:50AM	Want Better Returns? Don?t Ignore These 2 Medical Stocks Set to Beat Earnings (Zacks)
Apr-01-25 09:00AM	Here is What to Know Beyond Why Organon & Co. (OGN) is a Trending Stock (Zacks) -5.10%
07:30AM	Organon Acquires TOFIDENCE (tocilizumab-bavi), a Commercialized Biosimilar to ACTEMRA (tocilizumab) Injection, for Intravenous Infusion in the U.S. (Business Wire)
Mar-28-25 05:50PM	Organon (OGN) Stock Moves -0.34%: What You Should Know (Zacks)
06:00AM	European Medicines Agency (EMA) Validates Henlius and Organon Filing for Perjeta (pertuzumab) Biosimilar Candidate HLX11 (Business Wire)
Mar-27-25 06:00PM	Organon (OGN) Falls More Steeply Than Broader Market: What Investors Need to Know (Zacks)
Mar-21-25 05:50PM	Organon (OGN) Stock Declines While Market Improves: Some Information for Investors (Zacks)
Mar-19-25 09:00AM	Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Mar-10-25 12:01AM	MAY HEALTH APPOINTS SEASONED MEDTECH EXECUTIVE, COLBY HOLTSHOUSE, AS PRESIDENT AND CEO (PR Newswire)
Mar-08-25 09:00AM	New Analysis of Organon's VTAMA (tapinarof) cream, 1% Phase 3 Data Shows Atopic Dermatitis Disease Activity Remained Low After Treatment-Free Interval in Adults and Children 2 Years of Age and Older (Business Wire)
Feb-13-25 07:30AM	Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2024 (Business Wire) +11.02%
Jan-23-25 07:30AM	Organon To Report Fourth Quarter and Full Year 2024 Results and Host Conference Call on February 13, 2025 (Business Wire)
Jan-12-25 09:27AM	Is Organon Co. (OGN) the Best Medical Stock to Buy Under $20? (Insider Monkey)

Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women's health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Arjona Ferreira Juan Camilo	Head of R&D & CMO	Aug 11 '25	Option Exercise	0.00	11,519	0	28,899	Aug 12 04:05 PM
COX CARRIE SMITH	Director	May 14 '25	Buy	8.07	12,469	100,591	12,469	May 15 04:09 PM
Falcione Aaron	Chief Human Resources Officer	May 07 '25	Buy	8.77	5,500	48,235	62,974	May 07 12:13 PM
Weaver Kirke	Gen. Counsel & Corp. Secy.	May 06 '25	Buy	9.21	8,045	74,054	52,489	May 07 12:12 PM
Karp Daniel	Executive VP, Corp. Dev.	May 06 '25	Buy	8.24	3,500	28,828	46,669	May 07 12:09 PM
WALSH MATTHEW M	Chief Financial Officer	May 05 '25	Buy	8.82	11,400	100,548	144,484	May 06 01:59 PM
Ali Kevin	Chief Executive Officer	May 05 '25	Buy	8.80	34,000	299,370	282,731	May 06 01:58 PM
Falcione Aaron	Chief Human Resources Officer	Mar 31 '25	Option Exercise	0.00	18,732	0	59,237	Apr 02 05:45 PM
Karp Daniel	Executive VP, Corp. Dev.	Mar 31 '25	Option Exercise	0.00	34,677	0	44,515	Apr 02 05:44 PM
Stahler Rachel A	Chief Information Officer	Mar 31 '25	Option Exercise	0.00	18,334	0	78,994	Apr 02 05:43 PM
WALSH MATTHEW M	Chief Financial Officer	Mar 31 '25	Option Exercise	0.00	34,870	0	136,903	Apr 02 05:41 PM
Arjona Ferreira Juan Camilo	Head of R&D & CMO	Mar 31 '25	Option Exercise	0.00	8,865	0	20,552	Apr 02 05:40 PM
Weaver Kirke	Gen. Counsel & Corp. Secy.	Mar 31 '25	Option Exercise	0.00	21,376	0	45,668	Apr 02 05:39 PM
DiMarco Kathryn	Corporate Controller	Mar 31 '25	Option Exercise	0.00	23,435	0	40,211	Apr 02 05:35 PM
Nisita Vittorio	Head of Global Business Svcs	Mar 31 '25	Option Exercise	0.00	13,231	0	44,803	Apr 02 05:34 PM
Morrissey Joseph T. Jr.	Head of Manufacturing	Mar 31 '25	Option Exercise	0.00	21,483	0	73,275	Apr 02 05:33 PM
Ali Kevin	Chief Executive Officer	Mar 31 '25	Option Exercise	0.00	109,204	0	260,687	Apr 02 05:32 PM
Arjona Ferreira Juan Camilo	Head of R&D & CMO	Nov 07 '24	Option Exercise	0.00	6,446	0	13,987	Nov 08 04:17 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

OGN

Organon & Co

Upgrade your FINVIZ experience